Crystal structure of SIV matrix antigen and implications for virus assembly.

Crystal structure of SIV matrix antigen and implications for virus assembly.

Simian immunodeficiency virus (SIV) is closely related to human immunodeficiency virus (HIV), their matrix antigens (MAs) sharing some 50% sequence identity. MA is a component of Pr55Gag, the sole protein required for assembly of the virion shell. MA targets Pr55 to the plasma membrane, and facilita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Z, Belyaev, A, Fry, E, Roy, P, Jones, I, Stuart, D
Formato:	Journal article
Lenguaje:	English
Publicado:	1995

Ejemplares similares

Crystal structure of Swine vesicular disease virus and implications for host adaptation.
por: Fry, E, et al.
Publicado: (2003)

Structure of equine infectious anemia virus matrix protein.
por: Hatanaka, H, et al.
Publicado: (2002)

Properties of recombinant HIV and SIV antigens
por: Jowett, J, et al.
Publicado: (1992)

Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication
por: Kumudhini Preethi Haran, et al.
Publicado: (2018-03-01)

Cellular and humoral antigenic epitopes in HIV and SIV.
por: Nixon, D, et al.
Publicado: (1992)

Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens
por: Penaloza MacMaster, P, et al.
Publicado: (2016)

Atomic resolution structure of Moloney murine leukemia virus matrix protein and its relationship to other retroviral matrix proteins.
por: Riffel, N, et al.
Publicado: (2002)

Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies
por: Nuria Pedreño-Lopez, et al.
Publicado: (2020-03-01)

SIV INFECTION OF CYNOMOLGUS MACAQUES - ANALYSIS OF CTL DURING THE EARLY PHASE OF INFECTION, AND IMMUNIZATION PROTECTION EXPERIMENT USING RECOMBINANT SIV PROTEINS AS SOLID MATRIX-ANTIBODY-ANTIGEN (SMAA)
por: Hanke, T, et al.
Publicado: (1995)

Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
por: Melanie Schwerdtfeger, et al.
Publicado: (2019-05-01)

Structure of human Aichi virus and implications for receptor binding
por: Zhu, L, et al.
Publicado: (2016)

Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
por: Berkower I, et al.
Publicado: (2012-09-01)

HIV and SIV CTL escape: implications for vaccine design.
por: Goulder, P, et al.
Publicado: (2004)

Hepatitis A virus capsid structure
por: Stuart, D, et al.
Publicado: (2018)

Purification of antibody-antigen complexes containing recombinant SIV proteins: comparison of antigen and antibody-antigen complexes for immune priming.
por: Randall, R, et al.
Publicado: (1994)

The crystal structure of bluetongue virus VP7.
por: Grimes, J, et al.
Publicado: (1995)

GCM-SIV1.5: Optimal Tradeoff between GCM-SIV1 and GCM-SIV2
por: Ping Zhang
Publicado: (2023-01-01)

Crystal structure of equine rhinitis A virus in complex with its sialic acid receptor.
por: Fry, E, et al.
Publicado: (2010)

Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity.
por: Shruthi Ravimohan, et al.
Publicado: (2012-01-01)

Modeling the Effects of Morphine-Altered Virus Specific Antibody Responses on HIV/SIV Dynamics
por: Jones M. Mutua, et al.
Publicado: (2019-04-01)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang X, et al.
Publicado: (2012-09-01)

Understanding the benign nature of natural SIV infection: Implications for AIDS pathogenesis
por: Silvestri Guido
Publicado: (2006-12-01)

Correction: Early Emergence and Selection of a SIV-LTR C/EBP Site Variant in SIV-Infected Macaques That Increases Virus Infectivity
Publicado: (2013-01-01)

Correction: Early Emergence and Selection of a SIV-LTR C/EBP Site Variant in SIV-Infected Macaques That Increases Virus Infectivity.
por: Shruthi Ravimohan, et al.
Publicado: (2013-01-01)

Promotion of virus assembly and organization by the measles virus matrix protein
por: Zunlong Ke, et al.
Publicado: (2018-04-01)

Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV.
por: Nami Iwamoto, et al.
Publicado: (2021-01-01)

Mucosal SIV vaccines comprising inactivated virus particles and bacterial adjuvants induce CD8+T-regulatory cells that suppress SIV positive CD4+cell activation and prevent SIV infection in the macaque model.
por: Jean Marie eAndrieu, et al.
Publicado: (2014-06-01)

Monocytes in HIV and SIV Infection and Aging: Implications for Inflamm-Aging and Accelerated Aging
por: Zoey K. Wallis, et al.
Publicado: (2022-02-01)

Gut Microbiome Alterations During HIV/SIV Infection: Implications for HIV Cure
por: Katti R. Crakes, et al.
Publicado: (2019-05-01)

Structure determination from a single high-pressure-frozen virus crystal.
por: Burkhardt, A, et al.
Publicado: (2013)

Higher Virus Replication and Rapid Disease Progression Correlate Inversely With SIV tat exon 1 Evolution in Morphine-addicted SIV/SHIV-infected Macaques
por: Kumar Anil, et al.
Publicado: (2005-12-01)

Distinct Features of Germinal Center Reactions in Macaques Infected by SIV or Vaccinated with a T-Dependent Model Antigen
por: Maria Trovato, et al.
Publicado: (2021-02-01)

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
por: Sharpe, S, et al.
Publicado: (2001)

Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy
por: B. Ling, et al.
Publicado: (2017-12-01)

Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells
por: Omalla A. Olwenyi, et al.
Publicado: (2020-09-01)

Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
por: Hamimi C, et al.
Publicado: (2012-09-01)

Origin of rebound virus in chronically SIV-infected monkeys following treatment discontinuation
por: D. Barouch, et al.
Publicado: (2019-12-01)

The structure of foot-and-mouth disease virus.
por: Fry, E, et al.
Publicado: (2005)

Regulation of SIV antigen-specific CD4+ T cellular immunity via autophagosome-mediated MHC II molecule-targeting antigen presentation in mice.
por: Yi Jin, et al.
Publicado: (2014-01-01)

Siv som faglig guru
por: Bente Ruud, et al.
Publicado: (2023-10-01)